Novozymes A/S (OTCMKTS:NVZMY) Stock Passes Below 50 Day Moving Average – What’s Next?

Novozymes A/S (OTCMKTS:NVZMY) shares crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $67.84 and traded as low as $62.33. Novozymes A/S shares last traded at $62.59, with a volume of 10,314 shares changing hands.

Analysts Set New Price Targets

Several brokerages have weighed in on NVZMY. Citigroup cut Novozymes A/S from a “neutral” rating to a “sell” rating in a report on Thursday, October 17th. Berenberg Bank raised Novozymes A/S to a “strong-buy” rating in a report on Tuesday, September 24th.

Novozymes A/S Stock Performance

The company has a market cap of $29.31 billion, a price-to-earnings ratio of 39.61, a PEG ratio of 3.87 and a beta of 0.89. The business has a fifty day moving average price of $67.84 and a 200 day moving average price of $63.60.

Novozymes A/S Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, September 18th. Stockholders of record on Monday, September 9th were issued a dividend of $0.1678 per share. The ex-dividend date of this dividend was Monday, September 9th. Novozymes A/S’s dividend payout ratio (DPR) is currently 41.77%.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.